Cargando…
Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study
BACKGROUND: Direct-to-consumer (DTC) online prescription platforms (OPP) for sexual health represent a potential paradigm shift in the diagnosis and treatment for sexual dysfunctions in the way men seek care. Knowledge of patients' risk profile using these platforms is limited. AIM: To assess r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282969/ https://www.ncbi.nlm.nih.gov/pubmed/37351463 http://dx.doi.org/10.1089/tmr.2023.0010 |
_version_ | 1785061224965210112 |
---|---|
author | von Büren, Moritz Wülfing, Christian Schlager, Daniel Träger, Max Michael Daoud, Marcel Schröder, Florian Brookman-May, Sabine D. Gratzke, Christian von Büren, Johannes |
author_facet | von Büren, Moritz Wülfing, Christian Schlager, Daniel Träger, Max Michael Daoud, Marcel Schröder, Florian Brookman-May, Sabine D. Gratzke, Christian von Büren, Johannes |
author_sort | von Büren, Moritz |
collection | PubMed |
description | BACKGROUND: Direct-to-consumer (DTC) online prescription platforms (OPP) for sexual health represent a potential paradigm shift in the diagnosis and treatment for sexual dysfunctions in the way men seek care. Knowledge of patients' risk profile using these platforms is limited. AIM: To assess risk profiles of patients reaching out to health care professionals through their DTC. METHODS: Anonymized data originally collected between February 2021 to May 2022 by a DTC platform in the men's health care space were retrospectively analyzed. Data included the content of patient requests through a communication function, as well as the corresponding responses by the attending physician on staff. Each request was then assessed by two independent urologists and categorized by the level of the risk profile as well as the need to refer the patient to further medical evaluation. RESULTS: Of 585 patient requests, 531 (90.8%) were classified as low risk. In the high-risk group, 32 patients were recommended to schedule an urgent appointment at a specialist. Only three patients (0.5%) were advised to seek emergency care. The overall referral rate for both risk groups was 52.3%. The requests of 279 patients (47.7%) were assessed as digitally treatable. Almost all patients who were digitally treatable were low risk. Side effects accounted for only 9.6% of all requests in the low-risk group, compared with 46.3% in the high-risk group. CONCLUSION: Overall, low-risk levels in the requests of patients using a DTC platform were reported, with almost half of them suitable to be solved digitally, whereas the other half required referral to an in-person specialist. |
format | Online Article Text |
id | pubmed-10282969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-102829692023-06-22 Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study von Büren, Moritz Wülfing, Christian Schlager, Daniel Träger, Max Michael Daoud, Marcel Schröder, Florian Brookman-May, Sabine D. Gratzke, Christian von Büren, Johannes Telemed Rep Original Research BACKGROUND: Direct-to-consumer (DTC) online prescription platforms (OPP) for sexual health represent a potential paradigm shift in the diagnosis and treatment for sexual dysfunctions in the way men seek care. Knowledge of patients' risk profile using these platforms is limited. AIM: To assess risk profiles of patients reaching out to health care professionals through their DTC. METHODS: Anonymized data originally collected between February 2021 to May 2022 by a DTC platform in the men's health care space were retrospectively analyzed. Data included the content of patient requests through a communication function, as well as the corresponding responses by the attending physician on staff. Each request was then assessed by two independent urologists and categorized by the level of the risk profile as well as the need to refer the patient to further medical evaluation. RESULTS: Of 585 patient requests, 531 (90.8%) were classified as low risk. In the high-risk group, 32 patients were recommended to schedule an urgent appointment at a specialist. Only three patients (0.5%) were advised to seek emergency care. The overall referral rate for both risk groups was 52.3%. The requests of 279 patients (47.7%) were assessed as digitally treatable. Almost all patients who were digitally treatable were low risk. Side effects accounted for only 9.6% of all requests in the low-risk group, compared with 46.3% in the high-risk group. CONCLUSION: Overall, low-risk levels in the requests of patients using a DTC platform were reported, with almost half of them suitable to be solved digitally, whereas the other half required referral to an in-person specialist. Mary Ann Liebert, Inc., publishers 2023-06-13 /pmc/articles/PMC10282969/ /pubmed/37351463 http://dx.doi.org/10.1089/tmr.2023.0010 Text en © Moritz von Büren et al., 2023; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research von Büren, Moritz Wülfing, Christian Schlager, Daniel Träger, Max Michael Daoud, Marcel Schröder, Florian Brookman-May, Sabine D. Gratzke, Christian von Büren, Johannes Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study |
title | Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study |
title_full | Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study |
title_fullStr | Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study |
title_full_unstemmed | Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study |
title_short | Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study |
title_sort | assessment of patient risk profiles by a male sexual health direct-to-consumer prescription platform: a cross-sectional study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282969/ https://www.ncbi.nlm.nih.gov/pubmed/37351463 http://dx.doi.org/10.1089/tmr.2023.0010 |
work_keys_str_mv | AT vonburenmoritz assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT wulfingchristian assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT schlagerdaniel assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT tragermaxmichael assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT daoudmarcel assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT schroderflorian assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT brookmanmaysabined assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT gratzkechristian assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy AT vonburenjohannes assessmentofpatientriskprofilesbyamalesexualhealthdirecttoconsumerprescriptionplatformacrosssectionalstudy |